Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

Journal of Substance Abuse Treatment

Volumn 35, Issue 1, 2008, Pages 87-92

  Sullivan, Lynn E ^a   Moore, Brent A ^a   Chawarski, Marek C ^a   Pantalon, Michael V ^a   Barry, Declan ^a   O'Connor, Patrick G ^a   Schottenfeld, Richard S ^a   Fiellin, David A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine; HIV AIDS; Prevention; Risk reduction behavior; Treatment

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BEHAVIOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONDOM; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT DEPARTMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RATING SCALE; RISK; SEX; STATISTICAL SIGNIFICANCE;

ADULT; BUPRENORPHINE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NALOXONE; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE; RISK-TAKING; SEXUAL BEHAVIOR;

EID: 44349097414     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2007.08.004     Document Type: Article

References (29)

1. Camacho L.M., Bartholomew N.G., Joe G.W., Cloud M.A., and Simpson D.D. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug and Alcohol Dependence 41 (1996) 1-7
2. Camacho L.M., Bartholomew N.G., Joe G.W., and Simpson D.D. Maintenance of HIV risk reduction among injection opioid users: A 12 month posttreatment follow-up. Drug and Alcohol Dependence 47 (1997) 11-18
3. Catania J.A., Gibson D.R., Chitwood D.D., and Coates T.J. Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior. Psychological Bulletin 108 (1990) 339-362
4. Centers for Disease Control and Prevention. The global HIV/AIDS pandemic, 2006 MMWR. from (2006, August). http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5531a1.htm
5. Chawarski M.C., Mazlan M., and Schottenfeld R.S. Heroin dependence and HIV infection in Malaysia. Drug and Alcohol Dependence 82 Suppl. 1 (2006) S39-S42
6. Chawarski M.C., Pakes J., and Schottenfeld R.S. Assessment of HIV risk. Journal of Addictive Diseases 17 (1998) 49-59
7. Coates R.A., Calzavara L.M., Soskolne C.L., Read S.E., Fanning M.M., Shepherd F.A., et al. Validity of sexual histories in a prospective study of male sexual contacts of men with AIDS or an AIDS-related condition. American Journal of Epidemiology 128 (1988) 719-728
8. Fiellin D.A., Pantalon M.V., Chawarski M.C., Moore B.A., Sullivan L.E., O'Conner P.G., et al. Buprenorphine maintenance in primary care: A randomized controlled trial of counseling conditions and medication dispensing. New England Journal of Medicine 355 (2006) 365-374
9. Fiellin D.A., Pantalon M.V., Pakes J.P., O'Connor P.G., Chawarski M., and Schottenfeld R.S. Treatment of heroin dependence with buprenorphine in primary care. American Journal of Drug & Alcohol Abuse 28 (2002) 231-241
10. Gibson D.R., Flynn N.M., and McCarthy J.J. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 13 (1999) 1807-1818
11. Gowing L.R., Farrell M., Bornemann R., Sullivan L.E., and Ali R.L. Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine 21 (2006) 193-195
12. Johnson R.E., Eissenberg T., Stitzer M.L., Strain E.C., Liebson I.A., and Bigelow G.E. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence 40 (1995) 17-25
13. Kamb M.L., Fishbein M., Douglas J.M., Rhodes F., Rogers J., Bolan G., et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Journal of the American Medical Association 280 (1998) 1161-1167
14. Latkin C.A., and Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 93 (1998) 1191-1197
15. Latkin C.A., Vlahov D., and Anthony J.C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 88 (1993) 517-526
16. Ling W., Charuvastra C., Collins J.F., Batki S., Brown L.S., Kintaudi P., et al. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction 93 (1998) 475-486
17. Lott D.C., Strain E.C., Brooner R.K., Bigelow G.E., and Johnson R.E. HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate, buprenorphine, and methadone. Journal of Substance Abuse Treatment 31 (2006) 187-194
18. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 93 (1998) 515-532
19. Marsch L.A., Bickel W.K., Badger G.J., and Jacobs E.A. Buprenorphine treatment for opioid dependence: The relative efficacy of daily, twice and thrice weekly dosing. Drug and Alcohol Dependence 77 (2005) 195-204
20. Metzger D.S., Navaline H., and Woody G.E. Drug abuse treatment as AIDS prevention. Public Health Reports 113 (1998) 97-106
21. Prendergast M.L., Urada D., and Podus D. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Counseling and Clinical Psychology 69 (2001) 389-405
22. Saltzman S.P., Stoddard A.M., McCusker J., Moon M.W., and Mayer K.H. Reliability of self-reported sexual behavior risk factors for HIV infection in homosexual men. Public Health Reports 102 (1987) 692-697
23. Schroeder J.R., Epstein D.H., Umbricht A., and Preston K.L. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addictive Behaviors 31 (2006) 868-879
24. Semaan S., Des Jarlais D.C., Sogolow E., Johnson W.D., Hedges L.V., Remirez G., et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes 30 (2002) S73-S93
25. Sorensen J., and Copeland A. Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence 59 (2000) 17-31
26. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH multisite HIV prevention trial: Reducing HIV sexual risk behavior. Science 280 (1998) 1889-1894
27. UNAIDS. AIDS epidemic update-December 2003. Retrieved October 11, 2006, from (2003). http://www.UNAIDS.org
28. UNAIDS. 2006 report on the global AIDS epidemic (2006) (Geneva, Switzerland)
29. United Nations Office on Drugs and Crime. World drug report. from (2005). http://www.unodc.org/pdf/WDR_2005/volume_1_web.pdf